Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Laxmi Cotspin Ltd

LAXMICOT
NSE
14.55
4.40%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Laxmi Cotspin Ltd

LAXMICOT
NSE
14.55
4.40%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
25Cr
Close
Close Price
14.55
Industry
Industry
Textiles - Cotton Yarn - Open - Ended Spinning
PE
Price To Earnings
3.25
PS
Price To Sales
0.16
Revenue
Revenue
156Cr
Rev Gr TTM
Revenue Growth TTM
-5.40%
PAT Gr TTM
PAT Growth TTM
3,561.90%
Peer Comparison
How does LAXMICOT stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
LAXMICOT
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
414531313730564122515825
Growth YoY
Revenue Growth YoY%
-25.611.1-5.59.6-11.1-31.979.132.4-39.066.43.2-40.3
Expenses
ExpensesCr
414632323332594020485726
Operating Profit
Operating ProfitCr
0-10-14-2-32321-1
OPM
OPM%
0.1-2.5-0.2-3.49.7-6.3-4.63.611.44.62.1-4.8
Other Income
Other IncomeCr
00-1050017111
Interest Expense
Interest ExpenseCr
111111111111
Depreciation
DepreciationCr
111111111101
PBT
PBTCr
-2-3-3-27-4-40820-1
Tax
TaxCr
-100000000100
PAT
PATCr
-1-3-3-27-3-40710-1
Growth YoY
PAT Growth YoY%
-246.2-1,034.5-1,635.361.41,047.4-28.8-44.4112.63.5137.5110.9-648.1
NPM
NPM%
-1.8-6.1-8.3-6.919.6-11.5-6.70.733.22.60.7-6.0
EPS
EPS
-0.4-1.6-1.5-1.34.2-2.0-2.20.24.30.80.2-0.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
216143144150156
Growth
Revenue Growth%
-33.60.54.43.6
Expenses
ExpensesCr
204146143151151
Operating Profit
Operating ProfitCr
12-3105
OPM
OPM%
5.7-2.10.9-0.33.1
Other Income
Other IncomeCr
215910
Interest Expense
Interest ExpenseCr
32354
Depreciation
DepreciationCr
33332
PBT
PBTCr
8-7009
Tax
TaxCr
3-1001
PAT
PATCr
5-6008
Growth
PAT Growth%
-207.595.4272.11,563.1
NPM
NPM%
2.5-4.1-0.20.34.9
EPS
EPS
3.2-3.4-0.20.34.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
1717171717
Reserves
ReservesCr
3631464647
Current Liabilities
Current LiabilitiesCr
4341505044
Non Current Liabilities
Non Current LiabilitiesCr
1197610
Total Liabilities
Total LiabilitiesCr
10898120119117
Current Assets
Current AssetsCr
7769797171
Non Current Assets
Non Current AssetsCr
3129414947
Total Assets
Total AssetsCr
10898120119117

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-65-89
Investing Cash Flow
Investing Cash FlowCr
-4-2-1-5
Financing Cash Flow
Financing Cash FlowCr
9-310-5
Net Cash Flow
Net Cash FlowCr
0010
Free Cash Flow
Free Cash FlowCr
-65-817
CFO To PAT
CFO To PAT%
-104.5-81.23,127.72,046.2
CFO To EBITDA
CFO To EBITDA%
-46.5-159.2-641.2-2,191.2

Ratios

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
32314642
Price To Earnings
Price To Earnings
5.90.00.090.9
Price To Sales
Price To Sales
0.10.20.30.3
Price To Book
Price To Book
0.60.60.90.8
EV To EBITDA
EV To EBITDA
6.3-24.372.5-204.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.315.817.716.3
OPM
OPM%
5.7-2.10.9-0.3
NPM
NPM%
2.5-4.1-0.20.3
ROCE
ROCE%
10.9-5.32.54.5
ROE
ROE%
10.2-12.3-0.40.7
ROA
ROA%
5.1-6.0-0.20.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Laxmi Cotspin Limited is an Indian textile manufacturer undergoing a strategic pivot from traditional cotton yarn production toward high-value **Technical Textiles** and **Healthcare** products. Headquartered in **Jalna, Maharashtra**, the company operates an integrated business model encompassing ginning, pressing, and spinning. Historically a domestic player, the company has recently re-established its international presence, earning recognition as a **Star Export House** and migrating from the **NSE SME platform** to the **NSE Main Board** on **November 12, 2021**. --- ### **Core Manufacturing Infrastructure & Asset Rationalization** The company’s production facilities are strategically located in **Samangaon, Jalna**, within the high-yield cotton belts of Marathwada and Vidarbha. | Facility Type | Current Capacity / Equipment | | :--- | :--- | | **Spinning Unit** | **16,800 Spindles** (equipped with compact, lycra, and slub attachments) | | **Ginning & Pressing** | **48 DR** Ginning & Pressing unit | | **Storage** | **18,000 sq. ft.** raw material godown (NABARD supported) | | **Testing Lab** | Advanced quality control featuring **UT-5 (Uster Switzerland)**, **HVI**, and **Aqura** | **Strategic Asset Realignment:** In **May 2025**, the company initiated a modernization phase by closing its **Open-End division** and selling **4 Open-End machines (BD-6)** totaling **1,824 Rotors**. This move was accompanied by a reduction in power load from **2,048 KVA to 1,350 KVA** to optimize operational costs during a period of sluggish market sentiment. --- ### **Diversified Product Portfolio & Market Expansion** Laxmi Cotspin identifies **"Cotton"** as its primary segment but is aggressively diversifying its output to improve **Unit Value Realization (UVR)**. #### **1. Traditional Textile Segment** * **Yarn Varieties:** Premium **100% cotton** combed and carded hosiery, warp conventional, organic, and **BCI (Better Cotton Initiative)** yarn. * **Count Range:** **10s Ne to 40s Ne**. * **By-products:** Cotton bales, seeds, oil, and oil cakes. #### **2. Healthcare & Meditech (New Growth Engine)** The company has entered the healthcare sector through its subsidiary, **Laxmi Surgical Healthcare Pvt Ltd**. * **Flagship Product:** **OJAS COTTON ROLL** (Absorbent Cotton Wool I.P.). * **Timeline:** Trial production ran from **August 1 to September 9, 2025**; commercial production officially commenced on **September 10, 2025**. * **Target:** Full-scale commercialization of surgical cotton is slated for **FY 2025-26**, targeting both domestic and international medical markets. #### **3. Value-Added Garmenting** The Board approved the incorporation of a new subsidiary in **July 2025** dedicated to the manufacturing and trading of **readymade garments**, representing a forward integration move to capture higher margins. --- ### **Strategic Market Positioning & Logistics** * **Logistical Advantage:** Located **12 km from Jalna**, the plant benefits from proximity to a recently approved **Dry Port** and is **400 km** from **JNPT/Nhava Sheva** ports, significantly lowering export overheads. * **Global Standards:** The company holds **ISO 9001:2008**, **GOTS (Global Organic Textile Standards)**, **BCI Membership**, and **NOCA** certifications. It recently obtained the **OEKO-TEX certificate** to facilitate entry into European markets. * **Export Recovery:** After reporting **NIL** foreign exchange earnings in **FY 2022-23**, the company achieved **₹4,58,03,745** in exports in **FY 2023-24**, signaling a successful re-entry into global trade. --- ### **Corporate Structure & Subsidiary Management** Laxmi Cotspin Limited acts as the holding entity for three wholly-owned subsidiaries, each at different stages of operational maturity: | Subsidiary Name | Status & Strategic Purpose | | :--- | :--- | | **Laxmi Spintex Private Limited** | Currently active; involved in internal land transactions (approx. **₹7.5 Cr**) to consolidate assets. | | **Laxmi Surgical Healthcare Pvt Ltd** | The primary vehicle for the new **Surgical Cotton** and Meditech segment. | | **Laxmi Style & Design Private Ltd** | Incorporated **Sept 9, 2025**; currently under review for operational viability or potential strike-off. | --- ### **Financial Profile & Capital Structure** The company maintains a stable equity base but has seen an increase in debt to fund its diversification into healthcare. | Financial Metric (Rs. in Lakhs) | March 31, 2024 | March 31, 2023 | | :--- | :---: | :---: | | **Authorized Share Capital** | **4,000.00** | **4,000.00** | | **Paid-up Share Capital** | **1,714.77** | **1,714.77** | | **Total Borrowings** | **5,018.47** | **4,227.57** | | **Cash & Cash Equivalents** | **100.20** | **35.20** | | **Net Profit/Loss (Transferred to Reserves)** | **(31.00)** | — | * **Debt Management:** Loans are secured at an average cost of **8% to 10%**. Primary security includes a **first charge** on land, factory sheds, and machinery. * **Working Capital:** Supported by the **Emergency Credit Line Guarantee Scheme (ECLGS)** with a second ranking charge on existing collateral. * **Dividend:** No dividend was declared for the most recent fiscal year. --- ### **Risk Factors & Governance Challenges** Investors should note several **qualified conclusions** raised by statutory auditors as of **February 2026**: * **Internal Control Deficiencies:** Auditors highlighted a lack of a robust inventory management system. Valuation for **Q3 FY2025** relied on **management estimates** rather than physical verification. * **Regulatory Non-compliance:** A loan of **₹5.51 Crores** was advanced to **Laxmi Spintex Private Limited** without requisite Board approval or statutory compliance under the **Companies Act, 2013**. * **Asset Title Ambiguity:** Factory buildings are constructed on land (**Gut no 394**) held in the name of a **Director**, creating uncertainty regarding the company's legal claim to these fixed assets. * **Financial Recoverability:** Significant advances have been made to a creditor whose connected entities are under **financial stress**, with no impairment recognized under **Ind AS 109**. * **Contingent Liabilities:** * **Income Tax Demands:** **₹89.20 Lakhs** (under appeal). * **Arbitration Award:** **₹34.27 Lakhs + 15% interest** payable to C.A. Galiakotwala & Co. * **Bank Guarantees:** **₹252.90 Lakhs** committed to MSEB and Customs. --- ### **Future Outlook & Strategic Targets** Laxmi Cotspin is transitioning toward a **"Technical Textile"** identity. Key milestones for the upcoming period include: * **Operationalizing the Surgical Unit:** Achieving full commercial scale in **FY 2025-26**. * **Modernization:** Replacing the **old spinning unit** with high-efficiency technology to counter rising raw material costs and global competition. * **Leadership Continuity:** The Board has approved a revised managerial remuneration cap of **₹1 Crore** (effective **April 2025**) to retain key leadership during this transformative phase. * **Digital Integration:** Implementation of **Electronic Data Interchange (EDI)** and advanced IT systems to streamline the supply chain and improve transparency.